[ATX] YoY Quarter Result on 31-Mar-2019 [#Q4]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q4]
Profit Trend
QoQ- -60.45%
YoY- 36.07%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 1,221 674 34 -0 -77 616 1,447 -2.78%
PBT -3,542 -2,444 -1,368 -1,152 -1,802 -3,594 -2,808 3.94%
Tax -1,221 -674 -34 0 0 0 0 -
NP -2,322 -1,770 -1,334 -1,152 -1,802 -3,594 -2,808 -3.11%
Tax Rate - - - - - - - -
Total Cost 3,542 2,444 1,368 1,152 1,725 4,210 4,255 -3.00%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -190.17 -262.76 -3,898.12 273,022.75 2,337.94 -583.60 -194.09 -0.33%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.01 -0.02 -0.02 -0.03 -0.08 -0.16 -0.15 -36.30%
EPS Diluted -0.01 -0.02 -0.02 -0.03 -0.08 -0.16 -0.15 -36.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.